Simplifying Global Compliance
Amgen and Astellas Pharma have agreed to pay nearly $125 million to settle federal allegations that they exploited charities to protect the prices of their favored drugs. Read More
PhRMA, pressed on all sides by critics of its members’ insulin-pricing policies, on Thursday made its public pitch to be part of the solution and not just the problem. Read More
A Pennsville, New Jersey API manufacturer earned itself a Form 483 for quality violations at its facility, including failure to reject faulty drug substances and inadequate investigations of discrepancies. Read More
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing